265 related articles for article (PubMed ID: 32179531)
1. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments.
Olsson A; Wistrand-Yuen P; Nielsen EI; Friberg LE; Sandegren L; Lagerbäck P; Tängdén T
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179531
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments.
Wistrand-Yuen P; Olsson A; Skarp KP; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
Clin Microbiol Infect; 2020 Sep; 26(9):1214-1221. PubMed ID: 32224200
[TBL] [Abstract][Full Text] [Related]
3. Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases.
Olsson A; Allander L; Shams A; Al-Farsi H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2023 Nov; 62(5):106967. PubMed ID: 37716575
[TBL] [Abstract][Full Text] [Related]
4. Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.
Olsson A; Hong M; Al-Farsi H; Giske CG; Lagerbäck P; Tängdén T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0106521. PubMed ID: 34516251
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
[TBL] [Abstract][Full Text] [Related]
6. Automated time-lapse microscopy a novel method for screening of antibiotic combination effects against multidrug-resistant Gram-negative bacteria.
Ungphakorn W; Lagerbäck P; Nielsen EI; Tängdén T
Clin Microbiol Infect; 2018 Jul; 24(7):778.e7-778.e14. PubMed ID: 29108951
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
[TBL] [Abstract][Full Text] [Related]
8. Polymyxin Combinations Combat
Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of fortimicin antibiotic combinations against MDR Pseudomonas aeruginosa and resistome analysis of a whole genome sequenced pan-drug resistant isolate.
Kamel NA; Tohamy ST; Alshahrani MY; Aboshanab KM
BMC Microbiol; 2024 May; 24(1):164. PubMed ID: 38745145
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
[TBL] [Abstract][Full Text] [Related]
11. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
[TBL] [Abstract][Full Text] [Related]
12. Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
Brennan-Krohn T; Truelson KA; Smith KP; Kirby JE
J Antimicrob Chemother; 2017 Oct; 72(10):2775-2781. PubMed ID: 29091221
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.
Aye SM; Galani I; Yu H; Wang J; Chen K; Wickremasinghe H; Karaiskos I; Bergen PJ; Zhao J; Velkov T; Giamarellou H; Lin YW; Tsuji BT; Li J
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393492
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.
Cai Y; Lim TP; Teo J; Sasikala S; Lee W; Hong Y; Chan EC; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
Antimicrob Agents Chemother; 2016 Sep; 60(9):5238-46. PubMed ID: 27324776
[TBL] [Abstract][Full Text] [Related]
16. Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictions.
Olsson A; Malmberg C; Zhao C; Friberg LE; Nielsen EI; Lagerbäck P; Tängdén T
J Antimicrob Chemother; 2024 Feb; 79(2):391-402. PubMed ID: 38158772
[TBL] [Abstract][Full Text] [Related]
17. Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant
Wickremasinghe H; Yu HH; Azad MAK; Zhao J; Bergen PJ; Velkov T; Zhou QT; Zhu Y; Li J
Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33918040
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Erdem I; Kucukercan M; Ceran N
Chemotherapy; 2003 Dec; 49(6):294-7. PubMed ID: 14671429
[TBL] [Abstract][Full Text] [Related]
19. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
20. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
Montero MM; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Segura C; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP
J Glob Antimicrob Resist; 2019 Sep; 18():37-44. PubMed ID: 31154007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]